These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 12920210)
41. Exocytosis of Neutrophil Formyl peptide receptor-like 1 (fPRL1) results in downregulation of cytoplasmic fPRL1 in patients with purulent dermatitis. Ohara E; Kumon Y; Kobayashi T; Takeuchi H; Sugiura T Clin Vaccine Immunol; 2007 Jun; 14(6):678-84. PubMed ID: 17460114 [TBL] [Abstract][Full Text] [Related]
42. Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors. Forsman H; Dahlgren C Scand J Immunol; 2009 Oct; 70(4):396-402. PubMed ID: 19751275 [TBL] [Abstract][Full Text] [Related]
43. Human dendritic cells express functional formyl peptide receptor-like-2 (FPRL2) throughout maturation. Yang D; Chen Q; Gertz B; He R; Phulsuksombati M; Ye RD; Oppenheim JJ J Leukoc Biol; 2002 Sep; 72(3):598-607. PubMed ID: 12223529 [TBL] [Abstract][Full Text] [Related]
44. Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. Björkman L; Karlsson J; Karlsson A; Rabiet MJ; Boulay F; Fu H; Bylund J; Dahlgren C J Leukoc Biol; 2008 Feb; 83(2):245-53. PubMed ID: 17984291 [TBL] [Abstract][Full Text] [Related]
45. Involvement of formyl-peptide-receptor-like-1 and phospholipase D in the internalization and signal transduction of amyloid beta 1-42 in glial cells. Brandenburg LO; Konrad M; Wruck C; Koch T; Pufe T; Lucius R Neuroscience; 2008 Oct; 156(2):266-76. PubMed ID: 18723082 [TBL] [Abstract][Full Text] [Related]
46. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Resnati M; Pallavicini I; Wang JM; Oppenheim J; Serhan CN; Romano M; Blasi F Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1359-64. PubMed ID: 11818541 [TBL] [Abstract][Full Text] [Related]
47. Trp-Arg-Trp-Trp-Trp-Trp antagonizes formyl peptide receptor like 2-mediated signaling. Shin EH; Lee HY; Kim SD; Jo SH; Kim MK; Park KS; Lee H; Bae YS Biochem Biophys Res Commun; 2006 Mar; 341(4):1317-22. PubMed ID: 16476585 [TBL] [Abstract][Full Text] [Related]
48. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. Papayianni A; Serhan CN; Brady HR J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917 [TBL] [Abstract][Full Text] [Related]
49. Synthetic peptide MMK-1 is a highly specific chemotactic agonist for leukocyte FPRL1. Hu JY; Le Y; Gong W; Dunlop NM; Gao JL; Murphy PM; Wang JM J Leukoc Biol; 2001 Jul; 70(1):155-61. PubMed ID: 11435499 [TBL] [Abstract][Full Text] [Related]
50. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Fiore S; Serhan CN Biochemistry; 1995 Dec; 34(51):16678-86. PubMed ID: 8527441 [TBL] [Abstract][Full Text] [Related]
51. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met inhibits human monocyte-derived dendritic cell maturation via formyl peptide receptor and formyl peptide receptor-like 2. Kang HK; Lee HY; Kim MK; Park KS; Park YM; Kwak JY; Bae YS J Immunol; 2005 Jul; 175(2):685-92. PubMed ID: 16002663 [TBL] [Abstract][Full Text] [Related]
52. Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. Shen W; Proost P; Li B; Gong W; Le Y; Sargeant R; Murphy PM; Van Damme J; Wang JM Biochem Biophys Res Commun; 2000 May; 272(1):276-83. PubMed ID: 10872839 [TBL] [Abstract][Full Text] [Related]
53. A homolog of formyl peptide receptor-like 1 (FPRL1) inhibitor from Staphylococcus aureus (FPRL1 inhibitory protein) that inhibits FPRL1 and FPR. Prat C; Haas PJ; Bestebroer J; de Haas CJ; van Strijp JA; van Kessel KP J Immunol; 2009 Nov; 183(10):6569-78. PubMed ID: 19846866 [TBL] [Abstract][Full Text] [Related]
54. Kinetic and thermodynamic analyses of adhesion of a peptide, Trp-Lys-Tyr-Met-Val-D-Met (WKYMVm), and human formyl peptide receptor (hFPR). Cho JH; Cho K; Shin HS Biotechnol Lett; 2010 Jun; 32(6):773-9. PubMed ID: 20221845 [TBL] [Abstract][Full Text] [Related]
55. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. Chiang N; Takano T; Clish CB; Petasis NA; Tai HH; Serhan CN J Pharmacol Exp Ther; 1998 Nov; 287(2):779-90. PubMed ID: 9808710 [TBL] [Abstract][Full Text] [Related]
56. Functional and physical interactions between formyl-peptide-receptors and scavenger receptor MARCO and their involvement in amyloid beta 1-42-induced signal transduction in glial cells. Brandenburg LO; Konrad M; Wruck CJ; Koch T; Lucius R; Pufe T J Neurochem; 2010 May; 113(3):749-60. PubMed ID: 20141570 [TBL] [Abstract][Full Text] [Related]
57. Pituitary adenylate cyclase-activating polypeptide 27 is a functional ligand for formyl peptide receptor-like 1. Kim Y; Lee BD; Kim O; Bae YS; Lee T; Suh PG; Ryu SH J Immunol; 2006 Mar; 176(5):2969-75. PubMed ID: 16493055 [TBL] [Abstract][Full Text] [Related]
58. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1. Svensson L; Redvall E; Björn C; Karlsson J; Bergin AM; Rabiet MJ; Dahlgren C; Wennerås C Eur J Immunol; 2007 Jul; 37(7):1966-77. PubMed ID: 17559171 [TBL] [Abstract][Full Text] [Related]
59. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. Maddox JF; Hachicha M; Takano T; Petasis NA; Fokin VV; Serhan CN J Biol Chem; 1997 Mar; 272(11):6972-8. PubMed ID: 9054386 [TBL] [Abstract][Full Text] [Related]
60. A new insight into the role of "old" chemotactic peptide receptors FPR and FPRL1: down-regulation of chemokine receptors CCR5 and CXCR4. Le Y; Shen W; Li B; Gong W; Dunlop NM; Wang JM Forum (Genova); 1999; 9(4):299-314. PubMed ID: 10611407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]